Modus Therapeutics Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 123.2%.

Top 13 shareholders own 89.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
66.1%	Karolinska Development AB (publ)	23,761,390	€2.6m	0%	25.25%
7.66%	KDev Investments AB	2,752,516	€305.7k	0%	no data
5.78%	Hans Wigzell	2,076,283	€230.6k	0%	no data
4.82%	John Öhd	1,730,591	€192.2k	0%	no data
1.48%	Anders Bladh	531,550	€59.0k	0%	no data
0.88%	Nordnet AB (publ), Asset Management Arm	315,792	€35.1k	0%	0.01%
0.78%	Aktiebolaget Wigzellproduktion	280,162	€31.1k	0%	no data
0.54%	Ellen Donnelly	195,073	€21.7k	0%	no data
0.46%	Avanza Fonder AB	164,732	€18.3k	0%	no data
0.4%	Per Lindqvist	145,000	€16.1k	0%	no data
0.28%	Bo Hederstedt	100,000	€11.1k	0%	no data
0.068%	Claes Lindblad	24,327	€2.7k	0%	no data
0.0094%	FCG Fonder AB	3,386	€376.0	0%	no data